In an oral cancer model, decorin was aberrantly expressed in the cancer cells, and knockdown of decorin reduced angiogenic mediators, including VEGF and MMP9, and decreased angiogenesis21. This evidence concerns the gene VEGFA and lip and oral cavity carcinoma.